Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

LEVETIRACETAM IN SODIUM CHLORIDE

LEVETIRACETAM

Standard Dose
500MG/100ML (5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LEVETIRACETAM IN SODIUM CHLORIDE is listed in Drugs@FDA under application 219562 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVETIRACETAM Form and strength INJECTABLE;INTRAVENOUS - 500MG/100ML (5MG/ML) Sponsor CAPLIN Submission history Latest submission status date: 2025-01-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVETIRACETAM IN SODIUM CHLORIDE is listed in Drugs@FDA under application 219562 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVETIRACETAM Form and strength INJECTABLE;INTRAVENOUS - 500MG/100ML (5MG/ML) Sponsor CAPLIN Submission history Latest submission status date: 2025-01-16 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.